Patents by Inventor Alessandro Lapini Sacchetti

Alessandro Lapini Sacchetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDO-IMIDAZO RIFAMYCINS
    Publication number: 20210363143
    Abstract: The present invention relates to novel pyrido-imidazo rifamycins, characterized by a highly selective antibacterial activity and low absorption by oral route.
    Type: Application
    Filed: May 7, 2021
    Publication date: November 25, 2021
    Applicant: Biofer S.p.A.
    Inventors: Egidio MARCHI, Alessandro LAPINI SACCHETTI, Claudia ORI, Lisa PRETI
  • Pyrido-imidazo rifamycins
    Patent number: 11028086
    Abstract: The present invention relates to novel pyrido-imidazo rifamycins, characterized by a highly selective antibacterial activity and low absorption by oral route.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: June 8, 2021
    Assignee: BIOFER S.P.A.
    Inventors: Egidio Marchi, Alessandro Lapini Sacchetti, Claudia Ori, Lisa Preti
  • PYRIDO-IMIDAZO RIFAMYCINS
    Publication number: 20200157104
    Abstract: The present invention relates to novel pyrido-imidazo rifamycins, characterized by a highly selective antibacterial activity and low absorption by oral route.
    Type: Application
    Filed: December 18, 2019
    Publication date: May 21, 2020
    Applicant: Biofer S.p.A.
    Inventors: Egidio MARCHI, Alessandro LAPINI SACCHETTI, Claudia ORI, Lisa PRETI
  • Modus of administration of iron, and new formulations adapted for the said goal
    Patent number: 10543216
    Abstract: A new modus and a new regimen of administration of divalent iron relates to therapy of hyposideremia, at the same time reducing toxic side effects. New formulations containing divalent iron compounds are adapted to release iron for intrabuccal absorption, preferably by sublingual absorption, that achieve these objects.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: January 28, 2020
    Assignee: BIOFER S.P.A.
    Inventors: Patrizia Santi, Dario Bosi, Alessandro Lapini Sacchetti, Egidio Marchi, Cristina Padula
  • NEW MODUS OF ADMINISTRATION OF IRON, AND NEW FORMULATIONS ADAPATED FOR THE SAID GOAL
    Publication number: 20160151384
    Abstract: A new modus and a new regimen of administration of divalent iron relates to therapy of hyposideremia, at the same time reducing toxic side effects. New formulations containing divalent iron compounds are adapted to release iron for intrabuccal absorption, preferably by sublingual absorption, that achieve these objects.
    Type: Application
    Filed: July 9, 2014
    Publication date: June 2, 2016
    Inventors: Patrizia SANTI, Dario BOSI, Alessandro LAPINI SACCHETTI, Egidio MARCHI, Cristina PADULA
  • Low molecular weight complexes between iron and maltobionic acid, use thereof for intramuscular or subcutaneous administration in the treatment of anemic states, and new pharmaceutical compositions adapted for these uses
    Patent number: 8828967
    Abstract: New low molecular weight complexes between iron and maltobionic acid that can be administered parenterally, preferably intramuscularly or subcutaneously, in the treatment of anemic states, caused by iron deficiencies, and new pharmaceutical compositions adapted for this use. In particular, the invention provides a new complex between preferably trivalent iron and maltobionic acid that is characterized by a molecular weight Mw between 10,000 and 30,000 Da, by a polydispersity of 1.0-1.8 and by an iron content between 25% and 40% by weight.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: September 9, 2014
    Assignee: Biofer S.p.A.
    Inventors: Michele Autuori, Dario Bosi, Alessandro Lapini Sacchetti, Egidio Marchi
  • NEW LOW MOLECULAR WEIGHT COMPLEXES BETWEEN IRON AND MALTOBIONIC ACID, USE THEREOF FOR INTRAMUSCULAR OR SUBCUTANEOUS ADMINISTRATION IN THE TREATMENT OF ANEMIC STATES, AND NEW PHARMACEUTICAL COMPOSITIONS ADAPTED FOR THESE USES
    Publication number: 20130079298
    Abstract: New low molecular weight complexes between iron and maltobionic acid that can be administered parenterally, preferably intramuscularly or subcutaneously, in the treatment of anemic states, caused by iron deficiencies, and new pharmaceutical compositions adapted for this use. In particular, the invention provides a new complex between preferably trivalent iron and maltobionic acid that is characterized by a molecular weight Mw between 10,000 and 30,000 Da, by a polydispersity of 1.0-1.8 and by an iron content between 25% and 40% by weight.
    Type: Application
    Filed: June 8, 2011
    Publication date: March 28, 2013
    Applicant: BIOFER S.P.A.
    Inventors: Michele Autuori, Dario Bosi, Alessandro Lapini Sacchetti, Egidio Marchi